Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $49.37 Analyst target: $57.73 Upside: 16.93%
AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.